Two isoforms of the GH receptor, the full-length receptor (GHR L ) and a short isoform (GHR S ) that lacks the transmembrane and intracellular domains of GHR L , have been analyzed in rat tissue extracts by Western blotting and immunoprecipitation. Although quantitative estimates of GHR S and GHR L based on coprecipitation of [ 125 I]GH indicated similar amounts of both isoforms in tissue extracts, the 110 kDa band corresponding to GHR L was generally not detected on Western blots without enrichment by immunoprecipitation. Two bands with electrophoretic mobilities corresponding to 38 and 42 kDa were present in extracts prepared from liver, muscle, and adipocytes. Western blots of the GH binding protein in rat serum also revealed two bands, but these had electrophoretic mobilities corresponding to 44 and 52 kDa. After digestion by endoglycosidase F, a single band with an electrophoretic mobility corresponding to 31 kDa was detected in samples from adipocytes, liver or serum, indicating that GHR S retained in tissues is glycosylated less extensively than that in rat serum. Digestion with neuraminidase indicated that the smaller glycoproteins in tissue extracts lack sialic acid residues that are present in serum samples. Furthermore, endoglycosidase H degraded GHR S in liver extracts to a 31 kDa band but did not degrade serum samples, suggesting that tissues retain a high mannose form of GHR S . The abundance of GHR S or GHR L in tissues from male, virgin female, and pregnant rats was estimated from the amount of 125
I-GH that was bound to each isoform after immunoprecipitation. Liver contained more than 10 times as much GHR S per gram of tissue as fat or muscle. In liver, muscle, and fat, the amount of GHR S exceeded that of GHR L , sometimes by as much as 6-fold. GHBP levels in serum of females exceeded those in males, and rose even higher in pregnant females. The abundance of GHR S in all tissue extracts paralleled serum levels. In muscle and fat, the levels of GHR L did not differ in male, female and pregnant rats, whereas in liver, the pattern was similar to the GHR S pattern. In all tissues, pools of GHR S exceeded those of GHR L by a factor that grew larger as tissue and serum levels increased.
The half life of GHBP in serum was estimated to be 2.4 h in rats treated with cycloheximide, whereas that of GHR S was 20 min in liver and 8.5 h in fat. These results suggest that GHR S is synthesized in liver 8 times faster than it is released into serum, whereas synthesis in fat is less than 30% of the rate at which it is released into serum by all tissues. Therefore, liver appears to be the major source of GHBP in serum. Although secretion into the circulatory system accounts for little or perhaps none of its turnover in some tissues, GHR S pools in tissues do appear to be regulated, suggesting that GHR S may function primarily in the cells in which it is synthesized. (Endocrinology 139: 2824 -2830, 1998) I IN ALL SPECIES thus far examined, the GH receptor gene encodes at least two products: the membrane spanning, signal generating full length receptor (GHR L ) and the circulating GH binding protein (GHBP) which corresponds to the extracellular ligand binding domain of GHR L . In some species, GHBP arises from proteolytic cleavage of a membranespanning receptor (1) , but in rats and mice, the GHBP is synthesized from an alternately spliced mRNA in which exons encoding the transmembrane and cytosolic domains of GHR L are replaced with an exon that encodes a hydrophilic peptide (2, 3) . Recent experiments suggest that the GHBP in humans may also be formed from an alternately spliced mRNA transcript that codes for a receptor isoform that lacks most of the intracellular domain (4) . Although a similar truncated GHR transcript may also be produced in rat tissues, the circulating GHBP in rats appears to arise from the short isoform of the receptor (GHR S ) encoded by a 1.2-kB transcript (5) that is present in liver, kidney, muscle, fat, heart, and other tissues (6 -10) .
Earlier studies in this laboratory indicated that despite the absence of a transmembrane domain, adipocytes retain substantially more GHR S than GHR L . In cell free extracts, GHR S is almost exclusively associated with the particulate fraction (11) . GHR S appears to reside largely intracellularly because, in contrast to GHR L , only a small fraction of GHR S was sensitive to mild digestion of adipocytes with trypsin (11) . Immunohistochemical studies also indicate an association of GHR S with intracellular membranes and the nucleus (12, 13) . Newly synthesized GHR S in adipocytes consists of a pair of proteins with electrophoretic mobilities of 38 and 42 kDa (14) , which is smaller than the 44-and 52-kDa circulating GHBP (5) . These findings prompted us to study the relationship of the circulating GHBP to GHR S in tissues.
Materials and Methods

Animals and tissues
Male and female rats (150 -200 g) were obtained from Charles River Breeding Laboratories (Kingston, NY) and fed Purina 5008 rat diet ad libitum (Richmond, IN). In some experiments, pregnant rats were purchased and used on the 19th day of pregnancy. Procedures for animal husbandry and tissue harvesting were in accordance with protocols approved by the University of MA Medical School Animal Care and Use Committee. In each experiment adipocytes were prepared from the pooled perirenal and epididymal or parametrial fat obtained from 4 -10 rats by collagenase treatment, as previously described (15) . To inhibit protein synthesis, 1 ml of 0.2 mg/ml cycloheximide dissolved in saline was injected into the tail vein 15 min to 4 h before harvesting tissues. Under these conditions, leucine incorporation into liver proteins was completely inhibited for at least 1 h (16). Rats were killed either by cervical dislocation or by decapitation to recover blood samples.
Western blot analysis
Whole tissue extracts were prepared by a procedure designed to recover the entire tissue pool of GHR S regardless of its subcellular distribution. Pieces of freshly excised liver, quadriceps muscle, or adipose tissue weighing approximately 50 mg were sonicated for 5 seconds with a Branson sonicator equipped with a microtip in 500 l sample buffer (60 mm Tris, pH 8.8, 20% glycerol, 5% ␤-mercaptoethanol, and 2% SDS) and heated to 100°for 5 min Detergent extracts of the particulate fraction were prepared by homogenizing tissues in 0.25 m sucrose containing 1 mm EDTA (10 ml/g muscle or liver, 5 ml/ml adipocytes) using a Tissuemizer for muscle and liver or a Dounce homogenizer for adipocytes. The homogenates were sedimented at 16,000 ϫ g for 10 min and the resulting supernatants were then sedimented at 250,000 ϫ g for 1 h. The 250,000 ϫ g pellets were resuspended in extraction buffer (10 mm Tris, pH 8.0, 0.14 m sodium chloride, 0.025% sodium azide, 0.1% Triton X-100, 1 mm phenylmethylsulfonyl fluoride, 10 g/ml aprotinin, and 10 g/ml leupeptin) and clarified by centrifugation at 16,000 ϫ g for 10 min. Portions of the supernatant were mixed with an equal volume of 2ϫ sample buffer and stored at Ϫ20 C for Western blot analysis, or assayed to determine the abundance of GH receptor isoforms.
Samples were analyzed on 7.5 or 10% polyacrylamide gels and transferred electrophoretically to nitrocellulose membranes. The membranes were blocked for 16 h at 23 C in PBS containing blocking protein (3% BSA or 5% nonfat dry milk) and 0.02% sodium azide and then incubated for 3 h with the primary antiserum. After four washes with PBS plus 0.3% Tween 20, the membranes were incubated for 1 h in washing buffer plus blocking protein and donkey ␣-rabbit serum coupled to horseradish peroxidase (Amersham, Arlington Heights, IL). The membranes were again washed and proteins were detected using enhanced chemiluminescence.
Assay for GHR S and GHRL
Detergent extracts of tissues were prepared by homogenizing 0.2 g of liver, 0.4 g of muscle, or 0.4 g of fat in 5 ml buffer (10 mm Tris, pH 8.0, 0.14 m NaCl, 1% Triton X-100, 5 mm EDTA, 1 mm phenylmethylsulfonyl fluoride, 0.02% sodium azide) and clarified by centrifugation at 16,000 ϫ g for 10 min. Samples (50 -100 l) were incubated overnight at 23 C in 1.5 ml plastic centrifuge tubes containing 1 ml of 10 mm Tris, pH 8, 0.14 m sodium chloride, 0.1% Triton X-100, 0.1% hemoglobin, 0.02% sodium azide, 20 ng/ml [ 125 I]-hGH, and ␣-GHR S diluted 5000-fold or ␣-GHR L diluted 1000-fold. Immune complexes were recovered by adding 25 l of a 1:3 suspension of protein A-agarose beads (Sigma, St. Louis, MO) and gently agitating the sampes on a rocker platform for 2 h at 23 C. The beads were collected by centrifugation at 16,000 ϫ g for 1 min and washed twice with 1 ml of Tris saline plus 0.1% Triton X-100 before counting. To calculate receptor levels from the amount of bound GH, a 1:1 complex was assumed (17) .
Antibodies
␣-GHR S was obtained from rabbits immunized with a synthetic peptide (GPKYNSQHPHQEIDNHL), which differs from the 17 amino acids at the unique carboxyl end of GHR S only by the susbstitution of tyrosine for phenylalanine, and has been described previously (14) . ␣-GHR L was obtained from a rabbit immunized with the intracellular domain of GHR L fused to the maltose binding protein and has been described previously (14) . ␣-GHR S and ␣-GHR L are both highly specific and do not cross-react with the other GHR isoform. ␣-GHBP was obtained from rabbits immunized with recombinant rat GHBP and has been previously described (5) . It can detect both GHR isoforms as well as GHBP on Western blots. Affinity purified antisera were prepared using the respective antigens cross-linked to agarose beads. Nonspecific antibodies were removed by washing the beads with 10 mm Tris containing 0.5 m sodium chloride and specific antibodies were then eluted with 0.1 m glycine, pH 2.5, and collected in tubes containing 2 m Tris, pH 9 (final pH 8).
Results
Samples for analysis by Western blotting were prepared from the particulate fraction of adipocyte extracts because quantitative assays indicated that almost 90% of the GH binding activity for both receptor isoforms could be extracted from this fraction with detergents (14) . As shown in Fig. 1 , two bands were detected both in serum and in cell extracts, but the electrophoretic mobilities of the serum and adipocyte proteins differed. Whereas serum contained immunoreactive proteins with apparent sizes of 44 and 52 kDa, the corresponding proteins in adipocyte extracts were only 38 and 42 kDa. The GHBP isoforms in serum appear to be identical to those reported by Sadeghi et al. (5) , which were degraded to a single 31 kDa polypeptide by endoglycosidase F, demonstrating that they reflect heterogeneous glycosylation of the same protein. The higher electrophoretic mobilities of the bands corresponding to GHR S recovered from adipocytes suggests that this tissue pool is not the immediate precursor of the secreted GHBP.
To determine the size(s) of GHR S in other GH target tissues, extracts of liver and muscle were also analyzed by Western blotting. Freshly isolated tissues were disrupted by FIG. 1. The short isoform of the GH receptor in serum (A) or a detergent extract of adipocyte membranes (B). Membrane extracts were prepared by homogenizing cells in isotonic sucrose, sedimenting the postmitochondrial supernatant at 100,000 ϫ g for 1 h, and extraction of the resulting pellet with SDS. Samples corresponding to 1 l of rat serum or 30 mg of adipocytes were analyzed on a 10% polyacrylamide gel, transferred to a nitrocellulose membrane, and blotted with ␣-GHBP diluted 4000-fold. Proteins were detected by chemiluminescence after blotting with a secondary antibody coupled to horseradish peroxidase. sonication in buffer containing 2% SDS. Bands similar to those seen in particulate extracts of adipocytes were also seen when whole tissue extracts of liver, fat, and muscle were analyzed (Fig. 2) . Bands corresponding to the 44-and 52-kDa proteins in serum were not detected in extracts of any tissue, suggesting that these three tissues all retain forms of GHR S that differ from the GHBP released into the circulatory system. Because GHBP levels are higher in female than in male serum (5), and still higher levels are reported in pregnant rats (8), we analyzed tissue extracts from male, virgin female, and pregnant rats to determine whether GHR S pools that comigrate with GHBP might accumulate in these tissues.
The signals detected in Fig. 2 were much weaker than those shown in Fig. 1 despite loading the gel with protein samples large enough to cause slight distortion of some bands, consistent with the expected greater enrichment of GHR S in the particulate fraction than in the whole cell extract. Consequently, we sought to enrich for GHR S by homogenizing tissues in isotonic sucrose and isolating a particulate fraction from each tissue. Western blots of these samples are shown in Fig. 3a . In serum samples from virgin female rats, the 44-and 52-kDa bands were stronger than in samples from male rats, and these proteins appeared to be most abundant in samples from pregnant rats. A similar pattern was also seen for the 38-and 42-kDa bands in liver extracts. Furthermore the intensity of 35-and 50-kDa bands that appeared to be insignificant in extracts from male rat liver increased in proportion to the intensities of the 38-and 42-kDa bands and may reflect additional heterogeneity in the glycosylation of the polypeptide. The 35-kDa band might also reflect partial degradation of one of the larger bands. Finally, in pregnant liver extract a band at 110 kDa that corresponds to the expected size of GHR L was also apparent. The abundance of GHR S in muscle or fat extracts of virgin female and pregnant rats appeared to be similar to that of males. Prolonged exposure of the Western blot shows that adipose tissue and muscle extracts, like those of liver, also contain traces of the 35-and 50-kDa proteins (Fig. 3b) .
To compare the carbohydrate components of the GHBP in serum to that of GHR S in tissues, samples were analyzed by Western blotting after digestion with endoglycosidases. Samples from rat serum, liver, or adipocyte extracts were degraded with either endoglycosidase F, endoglycosidase H, or with neuraminidase. Endoglycosidase F reduced the 44-and 52-kDa bands from serum and the 38-and 42-kDa bands from adipocytes to 31 kDa (Fig. 4a) , indicating that these bands all contain the same polypeptide chain. No change in the electrophoretic mobility of the 38 and 42 kDa bands was seen when a liver sample was degraded with neuraminidase ( Fig. 4b) , suggesting that these glycoproteins lack terminal sialic acid residues that are accessible to the enzyme. In contrast, neuraminidase degraded both the 44-and 52-kDa bands of the serum sample to products with apparent sizes of 40 and 45 kDa, respectively, indicating that these serum proteins contain sialic acid residues that are accessible to the enzyme. Endoglycosidase H, which specifically cleaves the high mannose carbohydrates often found on immature glycoproteins, failed to degrade the 44-and 52-kDa bands of GHBP in a serum sample (Fig. 4c) , but it degraded the 38-and 42-kDa bands of GHR S from liver to a 31-kDa band indistinguishable from that produced by endoglycosidase F. These results suggest that the 38-and 42-kDa bands retained by tissues may represent immature, high mannose forms of GHR S . The incomplete digestion of GHBP by Endo F in Fig.  4c may reflect partial renaturation of the sample during the overnight digestion with EndoF, which works best on denatured glycoproteins.
Quantitative estimates of the abundance of GHR S , GHR L , and GHBP in tissue and serum samples that were analyzed by Western blotting were obtained by coprecipitation of [ 125 I]GH with antisera that immunoprecipitate GHR S or FIG. 2. The short isoform of the GH receptor in extracts of whole tissues. Tissues were disrupted by sonication in buffer containing SDS. Samples corresponding to 0.5 l of rat serum (A), 1 mg of kidney (B), 1 mg of adipocytes (C),1 mg of muscle (D), or 0.5 mg of liver (E) were analyzed by electrophoresis on a 7.5% polyacrylamide gel, transferred to a nitrocellulose membrane, and blotted as described in Fig. 1.   FIG. 3 . The short isoform of the GH receptor in tissues from male (M), female (F), and pregnant (P) rats. a, Detergent extracts were prepared and analyzed as described in Fig. 1 . Extracts representing 0.5 l serum, 5 mg liver, 10 mg fat, or 10 mg of muscle were analyzed. b, Prolonged exposure of the portion of Fig. 3a enclosed by the dashed lines. Fig. 5 , tissue levels of GHR S were generally more than 10 times higher in liver than in fat or muscle, when normalized to tissue weight. Serum levels of GHBP were higher in females than in males, and were higher in pregnant than in virgin females. Tissue levels of GHR S tended to parallel GHBP levels in serum, although differences between male and female or between pregnant and virgin female were not always statistically significant.
GHR L specifically. As shown in
Fat and muscle levels of GHR L were similar in male, virgin female, or pregnant rats. In liver, however, GHR L levels were higher in females than in males, and were even higher in pregnant females. In all three tissues, GHR S was consistently more abundant than GHR L . The largest differences in abundance of GHR S and GHR L were seen in tissues of pregnant rats, which contained 2 to 6 times more GHR S than GHR L . Thus high GHBP levels in serum coincided with increased ratios of GHR S /GHR L in tissues.
To gain further insight into the relationship between GHR S in tissues and GHBP in serum, we estimated the turnover of GHR S , GHR L , and GHBP in groups of rats that were given cycloheximide by iv injection and killed at various times thereafter. After inhibition of protein synthesis, GHR S levels in tissues of cycloheximide-treated rats initially declined at rates that appeared to be linear when plotted on a semilogarithmic scale (Fig. 6a) . GHR S declined much more quickly in liver than in adipose tissue or serum, with initial half lives of 20 min, 8.5 h, and 2.4 h, respectively. For comparison, we also estimated the half-life of GHR L in liver and adipose tissue. As shown in Fig. 6b , GHR L declined rapidly in both tissues, with initial half lives of 20 and 31 min, respectively. The initial rapid declines in GHR S and GHR L were not sustained, suggesting that these isoforms may be present in more than one tissue pool or that the inhibitory effect of cycloheximide on protein synthesis may diminish at later times. The results suggest that turnover and therefore synthesis of GHR S and GHR L are regulated independently and in a tissue specific manner. Estimates for the rates of biosynthesis of GHR S and GHBP in male rat tissues are shown in Table 1 . The relatively slow synthesis of GHR S in adipose tissue, and its low concentration in lymph (18) suggest that this tissue may secrete little or none of the GHBP in serum.
The relatively high rate of GHR S turnover in liver compared 125 I]-GH. Confidence intervals for female Ͼ male: a, P Ͻ 0.001, n ϭ 11; b, P Ͻ 0.05, n ϭ 11; pregnant Ͼ female: c, P Ͻ 0.001, n ϭ 9; d, P Ͻ 0.05, n ϭ 11; e, P Ͻ 0.01, n ϭ 11; pregnant Ͼ male: f, P ϭ 0.001, n ϭ 12; g, P Ͻ 0.005, n ϭ 12.
with that of GHBP in serum suggests that secretion of GHBP accounts for only a small fraction of GHR S turnover in the liver.
Discussion
Like the GHBP in serum, GHR S is retained in tissues as a doublet that reflects two different degrees of glycosylation. Although the two glycoproteins retained by tissues appear to be smaller than the two in serum, the numerical correspondence suggests that perhaps sialylation of the 38 kDa GHR S band shifts its electrophoretic mobility to that of the 44-kDa GHBP band, and sialylation of the 42 kDa GHR S band shifts its mobility to that of the 52-kDa GHBP band. Although the electrophoretic mobilities are all stated in units that correspond to the expected positions of polypeptide chains with the indicated masses, the masses of the carbohydrate chains are not precisely related to electrophoretic mobility and may differ from the values suggested by the shifts in mobility.
Sialylated GHR S does not appear to be retained in tissues, suggesting that when it is translocated to the Golgi, where sialylation is thought to occur, it is then rapidly secreted. The tissue pool of GHR S is therefore not the immediate precursor of the secreted GHBP and appears to remain in a high mannose form that is sensitive to digestion with endoglycosidase H. Therefore it might be expected to be confined to the endoplasmic reticulum. Alternatively, GHR S may reside in vesicles that do not fuse with the trans-Golgi network in which sialylation occurs. In contrast, the cellular GHR L pool appears to be sialylated, as indicated by its sensitivity to neuraminidase in cross-linking studies (19) . The absence of sialic acid in the GHR S retained in tissues is consistent with the suggestion that GHR S is largely intracellular, as indicated by the earlier finding that it is less sensitive than GHR L to mild digestion with trypsin (11) .
The glycosylation state of the cellular GHR S pool is consistent with the possibility that it is an intermediate in the GHBP secretory pathway that is retained within the endoplasmic reticulum. The relatively large size of the pool in rat liver and its high turnover relative to that of GHBP indicate that most of the GHR S is never secreted, and it is likely that little or none of the GHR S formed in other tissues is secreted. It is possible that intracellular GHR S pools represent biosynthesis in excess of that needed for secretion and are therefore simply degraded. However, the consistent relationship between the amounts of GHR S and GHR L in various tissues suggests that the pool sizes and subcellular locations of both isoforms may be regulated. The molecular features of GHR isoforms by which the cell distinguishes GHR S and GHR L are unknown, but the amino acid sequences diverge near the carboxyl end of the WSXWS motif, which is common to all cytokine receptors and known to influence their subcellular distribution. A large fraction of the homologous erythropoietin receptor is retained within cells, where it too appears to be incompletely glycosylated (20) . Amino acid substitutions in its WSXWS motif alter translocation of the erythropoietin receptor to the plasma membrane (21) , and a mutation in this motif that reduces transport to the cell surface has been reported for the GH receptor from the sex-linked dwarf chicken (22) . Therefore it has been suggested that the WSXWS motif is an important determinant of the structural (Fig. 3) .
FIG. 6. Tissue levels of GHBP, GHR S , and GHR L in rats treated with cycloheximide. GHBP and GHR S (a), and GHR L (b) were estimated in tissue extracts prepared from male rats treated with 1 mg/kg cycloheximide for the indicated times. Control values for GHBP were 2.42 Ϯ 0.11 pmol/ml; for GHR S , 1.85 Ϯ 0.14 pmol/g for liver and 0.403 Ϯ 0.052 pmol/g for fat; for GHR L , 1.12 Ϯ 0.19 pmol/g for liver and 0.364 Ϯ 0.069 pmol/g for fat. Results are means Ϯ SEM for groups of 6 -13 rats.
stability of cytokine receptors that influences their subcellular distribution. By interacting with this adjacent feature, the carboxyl end of GHR S might influence its subcellular distribution. Strong interaction of its carboxyl end with an integral membrane protein might also account for the recovery of GHR S in the particulate fraction of cell extracts. Additional studies are needed to determine how GHR isoforms become segregated within the cell and whether this segregation depends upon or causes the difference with respect to sialylation. Localization of GH and GHBP to the cell nucleus (12, 13) suggests that these proteins may act within cells to effect GH responses. Indeed, addition of GHBP to cultured human hepatoma cells modulates expression of the GH receptor gene (23, 24) . These findings raise the possibility that intracellular GHR S may act directly within the cells in which it is synthesized.
Present estimates (Fig. 5) for the abundance of both GHR S and GHR L in whole tissues from male rats are substantially larger than our earlier estimate for isolated adipocytes (11) and indicate that in adipose tissue the ratio of GHR S /GHR L is closer to 2 than 6. The previous estimates were based on extracts of the particulate fraction prepared from isolated adipocytes, and may have underestimated the tissue contents due to incomplete recovery of both isoforms in the particulate fraction. In addition, GHR L may be lost selectively during the preparation of adipocytes due to its location on the cell surface and its sensitivity to proteases that are present in collagenase preparations. Furthermore, cells other than adipocytes that are present in fat, such as endothelial cells, macrophages, or fibroblasts that may have lower GHR S /GHR L ratios than adipocytes could account for some of the difference in GHR S /GHR L ratios in these two studies.
The serum GHBP values reported for male and female rats in Fig. 5 are somewhat lower than estimates made by RIA (5) or ligand immunofunctional assay (25) . The differences between current and previous estimates (5, 25) are greater for females than for males, and may reflect differences in the age or strain of the animals rather than inadequacies of the techniques. It is also possible that endogenous GH might compete with [
125 I]GH and therefore lower our estimates for GHBP. This factor was minimized by use of a large excess of [ 125 I]GH for our immunoprecipitations.
Adipocytes lost GHR S with a t 1/2 of 40 min when they were incubated in vitro (11), more than 10 times as rapidly as the in vivo turnover reported here. In contrast, GH binding to adipocytes (15) suggested that GHR L turnover in isolated cells equalled the turnover rate in vivo. Therefore GHR S degradation by adipocytes in vivo is only a fraction of the maximum potential rate and may be inhibited by hormonal signals that are lost when tissues are removed from the rat. Inhibition of GHR S degradation might be expected to increase the size of tissue pools. At steady state, GHR S and GHR L appear to be synthesized at similar rates in liver because the tissue pools and turnover rates of both isoforms are similar. However, for the same reason, GHR S must be synthesized at less than 10% of the rate of GHR L in adipocytes. These findings suggest that tissue-specific factors may regulate both the synthesis and degradation of GHR S in adipocytes. Because Northern blots (3, 6 -10) and RNA protection assays (26) indicate that the transcripts that encode GHR S are more abundant in fat, liver, and other tissues than those that encode GHR L , translation of GHR S may be regulated in a tissue specific manner. Despite synthesis and degradation of GHR S in fat at rates that are more than 10 times slower than GHR L , liver and fat tissue both maintain substantial pools of GHR S , suggesting that synthesis and degradation may be regulated to maintain tissue pools of both isoforms. Increased turnover of GHR S in liver may reflect the need for faster synthesis to provide for secretion of circulating GHBP.
Soluble isoforms of hormone receptors, particularly those of cytokine receptors, are frequently found in serum (27) . Although these proteins interfere with hormone signaling by competing for ligands that could otherwise bind to membrane bound receptors, they can also enhance hormone action by slowing ligand clearance, and some can generate intracellular signals by interacting with signaling proteins such as gp130 (28, 29) . Evidence suggesting all these modes of action has been reported for GHBP (23, 24, 30 -33) . The size, turnover rates, and distinctive glycosylation of the GHR S pools in tissues raise the possibility that these or other modalities may also be implemented within the cells that synthesize GHR S .
